Marko Hyvonen

Affiliations: 
University of Cambridge, Cambridge, England, United Kingdom 
Area:
Structural biology, biophysics, biochemistry, fragment-based drug discovery
Google:
"Marko Hyvonen"

Children

Sign in to add trainee
Adrian Harrington grad student 2002-2006 Cambridge
Ye Gu grad student 2008-2012 Cambridge
Emily Blythe grad student 2012-2013 Cambridge
Jane Cat Donaldson grad student 2009-2014 Cambridge
Miglė Kišonaitė grad student 2014-2015 Cambridge
Xuelu Wang grad student 2012-2016 Cambridge
Ruoqi-Emma Xu grad student 2012-2016 Cambridge
Clare Henry grad student 2013-2017 Cambridge
Margherite Guiata grad student 2016-2017 Cambridge
Thomas Cotton grad student 2015-2019 Cambridge
Joseph McLoughlin grad student 2015-2019 Cambridge
Richard Zhou grad student 2019-2020 Cambridge
Teodors Pantelejevs grad student 2015-2021 Cambridge
Matthew Ratcliff grad student 2016-2021 Cambridge

Collaborators

Sign in to add collaborator
Florian Hollfelder collaborator 2005- Cambridge (Chemistry Tree)
David Spring collaborator 2010- Cambridge (Chemistry Tree)
Andrea Balan collaborator 2016- University of São Paulo - Institute of Biomedical Science
Morten Grotli collaborator 2018- University of Gothenburg, Sweden
Christopher Abell collaborator 2004-2020 University of Cambridge (UK) (Chemistry Tree)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Brear P, De Fusco C, Atkinson EL, et al. (2022) A fragment-based approach leading to the discovery of inhibitors of CK2α with a novel mechanism of action. Rsc Medicinal Chemistry. 13: 1420-1426
Battisti UM, Gao C, Nilsson O, et al. (2022) Serendipitous Identification of a Covalent Activator of Liver Pyruvate Kinase. Chembiochem : a European Journal of Chemical Biology
Brear P, Hyvönen M. (2022) Crystal structure of the Rho-associated coiled-coil kinase 2 inhibitor belumosudil bound to CK2α. Acta Crystallographica. Section F, Structural Biology Communications. 78: 348-353
Neun S, Brear P, Campbell E, et al. (2022) Functional metagenomic screening identifies an unexpected β-glucuronidase. Nature Chemical Biology
Karusheva Y, Ratcliff M, Mörseburg A, et al. (2022) The Common H202D Variant in GDF-15 Does Not Affect Its Bioactivity but Can Significantly Interfere with Measurement of Its Circulating Levels. The Journal of Applied Laboratory Medicine
Pantelejevs T, Hyvönen M. (2022) Divergent binding mode for a protozoan BRC repeat to RAD51. The Biochemical Journal. 479: 1031-1043
Atkinson EL, Iegre J, D'Amore C, et al. (2022) Development of small cyclic peptides targeting the CK2α/β interface. Chemical Communications (Cambridge, England). 58: 4791-4794
Nain-Perez A, Foller Füchtbauer A, Håversen L, et al. (2022) Anthraquinone derivatives as ADP-competitive inhibitors of liver pyruvate kinase. European Journal of Medicinal Chemistry. 234: 114270
Synakewicz M, Eapen RS, Perez-Riba A, et al. (2022) Unraveling the Mechanics of a Repeat-Protein Nanospring: From Folding of Individual Repeats to Fluctuations of the Superhelix. Acs Nano. 16: 3895-3905
Talbot-Cooper C, Pantelejevs T, Shannon JP, et al. (2022) Poxviruses and paramyxoviruses use a conserved mechanism of STAT1 antagonism to inhibit interferon signaling. Cell Host & Microbe
See more...